KALA · KALA BIO, Inc.
AI read · Bad for KALA
The AI's read
The permission does not remove KALA's listing problem. KALA still has to meet the required closing-price tests and follow other Nasdaq rules. The panel can reconsider, and KALA says it cannot assure it will comply. Those risks outweigh the temporary permission to stay listed.